List view / Grid view
3 December 2014 | By Prothena
Prothena initiates NEOD001 global Phase 3 registrational trial based on positive results in ongoing phase 1/2 study of NEOD001 in Patients With AL Amyloidosis...
2 December 2014 | By Roche
Victory for patients as NICE accepts Gazyvaro™ (obinutuzumab) for treatment of most common adult leukaemia1...
2 December 2014 | By The Republic of Sierra Leone
The Chief Medical Officer of the Ministry of Health and Sanitation, Dr Brima Kargbo, will host an online press conference on Wednesday, December 3rd, 2014 at 15 GMT...
2 December 2014 | By Distributed by APO (African Press Organization) on behalf of #TackleEbola
The multimedia campaign is the first to directly engage Ebola survivors in delivering key protective messages...
2 December 2014 | By Inventiva
This follows an earlier positive opinion for IVA337 in October regarding the treatment of Systemic Sclerosis (SSc)...
2 December 2014 | By Exco InTouch
Exco InTouch, the leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, will speak in two mHealth Solutions sessions focused on disease management at the annual mHealth Summit on Monday, 8th and Tuesday 9th December 2014...
2 December 2014 | By Roche
Roche announced the acquisition of Ariosa Diagnostics, Inc. (Ariosa), a privately-held company based in San Jose, California, USA...
2 December 2014 | By The Bristol-Myers Squibb Foundation
The Bristol-Myers Squibb Foundation marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Saharan Africa for adolescents and the elderly who are living with HIV and for HIV patients with comorbid female cancers or tuberculosis...
2 December 2014 | By MWV
Global packaging company has received a grant from The Bill & Melinda Gates Foundation to improve adherence and accuracy during PrEP trials...
1 December 2014 | By Kakushin Webinars
Dr. Gurpreet Sandhu, Reva Pharmachem Managing Director, shared the following in regard to Drug Manufacturing in Russia...
1 December 2014 | By Janssen-Cilag International
Janssen-Cilag International NV (Janssen) announced today the submission of a Type II variation application to the European Medicines Agency (EMA) to vary the marketing authorisation for IMBRUVICA® (ibrutinib), to include a new therapeutic indication, the treatment of adult patients with Waldenström’s macroglobulinemia (WM). If approved, this latest regulatory submission will…
1 December 2014 | By Arthurian Life Sciences
Arthurian Life Sciences, the specialist fund management company led by Professor Sir Chris Evans, announced it has formed a partnership with one of the leading medtech firms in the US, Interrad Medical Inc...
1 December 2014 | By Treeway
Treeway B.V. is pleased to announce that the European Medicines Agency has granted orphan drug designation for TW001 for the treatment of ALS...
1 December 2014 | By Futura Medical
Futura Medical plc, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that it will shortly be making a submission to UK regulators for approval to begin a clinical study to assess the efficacy and safety of its three topical pain relief products, which have already…
28 November 2014 | By Public Health England
Almost two months since the launch of the seasonal flu vaccine campaign, the first monthly uptake figures show an encouraging start, but Public Health England (PHE) is urging all at risk people not to ‘put off’ getting the vaccination until flu is circulating more widely...
